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Abstract
The main aim of this paper was to assess the in vitro response of healthy and coeliac
human faecal microbiota to gluten-friendly bread (GFB). Thus, GFB and control bread (CB)
were fermented with faecal microbiota in pH-controlled batch cultures. The effects on the
major groups of microbiota were monitored over 48 h incubations by fluorescence in situ
hybridisation. Short-chain fatty acids (SCFAs) were measured by high-performance liquid
chromatography (HPLC). Furthermore, the death kinetics of Lactobacillus acidophilus, Bifi-
dobacterium animalis subsp. lactis, Staphylococcus aureus, and Salmonella Typhimurium
in a saline solution supplemented with GFB or CB were also assessed. The experiments in
saline solution pinpointed that GFB prolonged the survival of L. acidophilus and exerted an
antibacterial effect towards S. aureus and S. Typhimurium. Moreover, GFB modulated the
intestinal microbiota in vitro, promoting changes in lactobacilli and bifidobacteria members
in coeliac subjects. A final multivariate approach combining both viable counts and metabo-
lites suggested that GFB could beneficially modulate the coeliac gut microbiome; however,
human studies are needed to prove its efficacy.
Introduction
Coeliac disease is a chronic immune-mediated enteropathy triggered by the ingestion of gluten
in HLA-DQ2- or HLA-DQ8-positive people. Approximately 30% of the general population
carries the HLA-DQ2/8 coeliac disease susceptibility genes; however, only 2–5% of these indi-
viduals will go on to develop coeliac disease, suggesting that additional environmental factors
contribute to the disease development [1]. Many authors have reported that coeliac people suf-
fer from an altered composition of gut microbiota [2,3], such as lower levels of Bifidobacterium
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spp. and Lactobacillus spp. [4,5]; higher levels of Bacteroides, Escherichia coli, Staphylococcus
and Clostridium [4,6–8]; and an altered profile of short-chain fatty acids (SCFAs) [4,9]. The
link between an altered gut microbiota composition and disease is a matter of debate, as some
authors have suggested that this change could be both an effect of disease and the cause of
some symptoms [10].
To date, the only treatment for coeliac patients is the complete lifelong exclusion of gluten
from the diet, but a gluten-free diet does not completely restore healthy microbiota profiles
[11]. An alternative to the exclusion of gluten is its detoxification without affecting the techno-
logical performance of the flour and dough. Some approaches for gluten detoxification have
been proposed and studied in the past, e.g. the use of protease produced by lactic acid bacteria
[12] or the transdamidation [13]. Recently, we developed a new and innovative method to
detoxify gluten proteins from cereal grains with the purpose of combining the nutritional and
technological properties of wheat proteins with safety for coeliac and gluten-sensitive patients
[14,15]. This innovation is usually referred to as “gluten friendly” and relies on the application
of microwave energy for a few seconds to hydrated wheat kernels before milling to reach a high
temperature for a short amount of time and induce a structural change in gluten proteins [16].
This modification abolishes the antigenic capacity of gluten [16] and reduces in vitro the
immunogenicity of the most common epitopes involved in coeliac disease [17], without
compromising the nutritional and technological properties necessary to process semolina in
pasta and flours in bread and other baked goods [16]. Additionally, the technology has been
further improved [18].
Scaling up a new technology is a complex process because many issues must be addressed.
For a gluten-friendly approach, we have only assessed the effect of microwave on gluten pro-
teins [16], and the industrial scale-up is in progress. This paper addresses the effect of gluten-
friendly bread (GFB) on the gut microbiota composition through two intermediate steps:
1. Assessing the effect on certain foodborne strains (both probiotic and pathogenic) to pin-
point whether the addition of GFB modifies the survival of these selected targets under strict
controlled conditions. This step was necessary to select and/or design an experiment evalu-
ating the effects of GFB in a complex system;
2. Investigating the effect of GFB on faecal human microbiota in healthy and coeliac subjects
in a pH-controlled, stirred, batch-culture fermentation system that is reflective of the envi-
ronmental conditions of the distal region of the human large intestine, with a focus on the
viable count of certain microbial groups and the production of SCFAs.
Materials and Methods
Rawmaterials and microwave treatment
The Casillo group S.p.a (Corato, Italy) supplied the wheat kernels (mixtures of soft wheat
Canadian grains; the exact composition of the mixtures was not specified). Flour treated with
microwaves was called gluten-friendly flour (GFF) and was obtained by milling the micro-
wave-treated caryopses [18]. One hundred grams of cleaned wheat grains were dampened until
reaching 15–18% humidity, which was measured by a halogen thermal balance (Mettler
Toledo, HB43-S, Switzerland), and subjected to rapid heating via microwaves (Delonghi, Italy,
approximately 1 min. between 1000 and 750 watts), followed by slow evaporation of the water.
The rapid heating and subsequent slow evaporation of the water was repeated until reaching a
final temperature of 80–90°C, which was measured by a thermal camera (Fluke, i 20 model,
Italy), and a moisture degree of 13–13.5% in the wheat grains.
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After microwave treatment, the wheat kernels were cooled and dried at room temperature
(24°C) for 12–24 h and then ground using an automatic laboratory mill MCKA (Bühler AG,
Azwil, Switzerland, diameter of grid 118–180 μm). The flour produced by milling caryopses
that had not been treated with microwaves was called control flour (CF). The particle size of
the GFF and the CF used was in the range of 100 to 200 μm.
Bread production and digestion
Bread was produced by using either CF (control bread, CB) or GFF (GFB) according to the
Chorleywood Bread Process in the Food Processing Centre of the Department of Food and
Nutritional Sciences at the University of Reading (UK). Bread was prepared as follows: flour,
100 g; water, 66 mL; baker’s yeast, 1.33 g; and salt, 1 g. Allinson Easy Bake Yeast (UK) has been
used as a dried yeast with the bread improver Ascorbic Acid (Vitamin C).
Simulated in vitro human digestion
Bread was digested in vitro under appropriate conditions according to the procedures
described by Maccaferri et al. [19] in order to mimic mouth, stomach and intestine’s condition.
The only modification to the method described by Macaferri et al. [19] was to not apply any
form of dialysis to the samples.
In vitro experiments
Microorganisms. Lactobacillus acidophilus La-5, Bifidobacterium animalis subsp. lactis
Bb-02, Salmonella Typhimurium and Staphylococcus. aureus were used throughout this
research. L. acidophilus and B. animalis were purchased from Chr. Hansen and stored at -20°C
in MRS broth (Oxoid, Milan, Italy) supplemented with 33% sterile glycerol (J.T. Baker, Milan).
The pathogens were food-borne isolates belonging to the culture collection of the Laboratory
of Predictive Microbiology, University of Foggia; the strains were stored at 4°C on tryptone
soya agar slants (Oxoid).
Before each assay, the microorganisms were grown at 37°C for 24 h in the optimal media
(MRS broth or TSB broth); the cultures were centrifuged two times at 1000 g for 10 min, and
the cells were suspended in sterile distilled water.
Samples and microbiological analyses. Two different sets of experiments were per-
formed, as reported in Table 1. Aliquots of saline solution (0.9% NaCl) (50 mL) were supple-
mented with different amounts of dried CB or dried GFB and inoculated to approximately 8
log CFU mL-1; the samples were periodically analysed to assess the viable count by plating on
MRS agar (L. acidophilus and B. animalis) or TSA (Salmonella sp., S. aureus) and incubating at
37°C for 2–4 days. L. acidophilus and B. animalis were assessed under anaerobic conditions.
Modelling and statistics. The experiments were performed on two different batches in
duplicate (n = 2).
The results of the viable count were fitted using the Weibull equation in the log-linear
form [20]:
logN ¼ logN0  t d= Þpð
where log N is the cell count over time (log CFU mL-1); log N0 is the initial cell count; δ is the
ﬁrst reduction time (day), i.e., the time to attain a decrease in cell count of 1 log CFU mL-1;
and p is the shape parameter (p>1, downward curve; p<1, upward curve).
The data were also modelled through Weibull equation, as modified by Bevilacqua et al.
[21], to evaluate the death time of the population.
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The fitting parameters of the Weibull equation, as well as the viable counts, were analysed
by one-way analysis of variance (ANOVA) and Tukey’s test as the post-hoc comparison test
(P<0.05). Statistics were performed in Statistica software for Windows (StatSoft, Tulsa, OK).
Batch culture fermentation
Collection and faecal sample preparation. Faecal samples were obtained from three
healthy human volunteers (two males, one female; age 30 to 38 years; BMI, body mass index of
18.5–25) who were free of known metabolic and gastrointestinal diseases (e.g., diabetes, ulcera-
tive colitis, Crohn’s disease, irritable bowel syndrome, peptic ulcers and cancer). All healthy
faecal donors had the experimental procedure explained to them and were given the opportu-
nity to ask questions. All donors then provided written informed consent for the use of their
faeces in the study, and a standard questionnaire to collect information regarding the health
status, drug use, clinical anamnesis, and lifestyle was administered before the donor was asked
to provide a faecal sample. For the coeliac donors (two females, one male; age 30 to 38 years;
BMI of 18.5–25), written informed consent was also obtained, and the in vitro study was
approved by the University of Reading Research Ethics Committee (UREC 15/20). All faecal
samples from healthy and coeliac donors were collected on site, stored in an anaerobic cabinet
(10% H2, 10% CO2 and 80% N2) and used within a maximum of 15 min after collection. The
samples were diluted 1/10 wt/vol in anaerobic phosphate-buffered saline (PBS, 0.1 M phos-
phate buffer solution, pH 7.4) and homogenised (Stomacher 400, Seward, West Sussex, UK)
for 2 min (460 paddle-beats/min). To maintain the anaerobic conditions, the PBS was main-
tained in anaerobic cabins until the time of use. The resulting faecal slurries from each individ-
ual were used to inoculate the batch-culture systems.
Batch culture fermentations. Previously sterilized batch culture fermentation vessels (280
mL working volume) were filled with 45 mL of sterile complex colonic model growth medium.
The composition of this medium included peptone water (5 g L-1), yeast extract (4.5 g L-1),
starch (5 g L-1), tryptone (5 g L-1), NaCl (4.5 g L-1), KCl (4.5 g L-1), mucin (4 g L-1), casein
(3 g L-1), pectin (2 g L-1), xylan (2 g L-1), arabinogalactan (2 g L-1) and inulin (1 g L-1) [22]. All
media and chemicals were purchased from Oxoid and Sigma. Then, the vessels were connected
to a circulating water bath at 37°C and sparged with O2-free N2 gas overnight to attain anaero-
bic conditions. The pH was adjusted to between 6.7 and 6.9 using pH meter controllers with
NaOH or HCl (Electrolab260; Electrolab Ltd., Tewkesbury, UK), and 5 mL of faecal slurry was
then inoculated in each vessel. In total, eighteen vessels were prepared and supplemented with
1 mL of CB or GFB digesta (3 vessels per type of donor, including a negative control, i.e., a sam-
ple containing faecal slurry but without bread, and samples with CB and GFB). The batch cul-
tures were run for 48 h, and 5 mL of the samples were removed at 0, 6, 24 and 48 h for analysis
Table 1. Conditions used to assess the effect of control bread and gluten friendly bread towards L. acidophilus, B. animalis, Salmonella sp. and S.
aureus in saline solution.
Experiments Targets Samples Duration
Death kinetics L. acidophilus B. animalis Saline solution and samples supplemented with 0.4 or 0.8 g L-1 of
either CB or GFB*
7 days (viable count every
6–10 h)
Effect of
concentration
L. acidophilus B. animalis Saline solution and samples supplemented with 0.8 or 5.0 g L-1 of
either CB or GFB
24 h
Pathogens Salmonella Typhimurium S.
aureus
Saline solution and samples supplemented with 0.2, 0.4, or 0.8 g L-1
of either CB or GFB
7 days (viable count after 1
and 7 days)
*CB, control bread; GFB, gluten friendly bread.
doi:10.1371/journal.pone.0162770.t001
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of bacterial populations by fluorescence in situ hybridisation (FISH) and SCFA analysis by
high-performance liquid chromatography (HPLC).
Enumeration of bacterial populations by fluorescence in situ hybridisation (FISH).
FISH was performed as described by Costabile et al. [23]. A 375 μL aliquot of the batch culture
samples was fixed in three volumes of ice-cold 4% (w/v) paraformaldehyde for 4 h at 4°C, cen-
trifuged at 13,000 g for 5 min and washed twice in 1 mL of sterile PBS. The cells were again pel-
leted by centrifugation and re-suspended in 150 μL of sterile PBS, to which 150 μL of ethanol
was added. The samples were then mixed and stored at -20°C until used.
All probes were synthesised by Sigma-Aldrich. The following bacterial groups were identi-
fied using synthetic oligonucleotide probes that target specific regions of the 16S ribosomal
RNA molecule, labelled with the fluorescent dye Cy3: Clostridium hystolyticum clusters I/II
(Chis150, TTATGCGGTATTAATCTYCCTTT) [24], Lactobacillus/Enterococcus spp. (Lab158,
GGTATTAGCAYCTGTTTCCA) [25], Clostridium clusters XIVa+b (Erec482, GCTTCTTAGT
CARGTACCG) [24], Bacteroides/Prevotella group (Bac303, CCAATGTGGGGGACCTT) [26], Bifi-
dobacterium spp. (Bif164, CATCCGGCATTACCACCC) [27] and Eub338 I-II-III
(GCTGCCTCCCGTAGGAGT, GCAGCCACCCGTAGGTGT, GCTGCCACCCGTAGGTGT) [28].
Short-chain fatty acid (SCFA) analysis. Samples were taken from the batch culture ves-
sels at each time point, and cell-free culture supernatants were obtained by centrifuging 1 mL
at 13000 x g for 10 min, followed by filter sterilisation (0.2 μm Acrodisc1 syringe filters with a
hydrophilic polyvinylidene fluoride (PVDF) membrane, 13 mm; Pall Corporation) to remove
particulate matter. The SCFA content was quantified on an ion exclusion HPLC (LaChrom
Merck Hitachi, Poole, Dorset, UK) instrument equipped with a pump (L-7100), RI detector (L-
7490) and autosampler (L-7200). Samples (20 μL) were injected into the HPLC at a flow rate of
0.5 mL min-1 with a prepacked Rezex ROA–Organic Acid H+ 80% (300 x 7.8 mm) column at
84°C and a detector wavelength of 210 nm. H2SO4 (2.5 mM) was used as the eluent, and the
organic acids (lactic, acetic, propionic and butyric) were calibrated against standards at concen-
trations of 12.5, 25, 50, 75 and 100 mM. An internal standard of 2-ethylbutyric acid (20 mM)
was included in the samples and external standards. All chemicals were provided from Sigma-
Aldrich.
Statistical analysis. The results from the FISH and SCFA analyses were standardized and
reported as increases/decreases relative to t0 of the negative control (beginning of the experi-
ment). The results were first analysed through one-way ANOVA and Tukey’s test using the
homogeneous group approach [29]. The classical approach of one-way ANOVA and post-hoc
offers an overview of the significant differences amongst different samples. However, it does
not work well if the studied parameter does not show or possess well-defined statistical groups
and is distributed in a continuous way and if each sample can be attributed to different statisti-
cal groups. When this type of distribution is observed in the results, the use of ANOVA by
homogeneous groups is advisable: the parameters are organized in a table with different col-
umns (homogeneous groups), and each column contains the samples belonging to the same
homogeneous group. The novelty relies upon the fact that the same sample can be attributed to
many groups.
Thereafter, the FISH and SCFA values were used as input data to run 3 different principal
component analysis (PCA; for the results after 6, 24, and 48 h) experiments.
As a confirmatory experiment, a second standardization of the data was performed, i.e., for
each sampling time, the results from healthy and coeliac donors supplemented with CB or GFB
were reported as increases/decreases relative to the negative control at the same time, and the
results were then analysed through one-way ANOVA. This type of modelling was used to
exclude possible prebiotic activities of CB or GFB on both healthy and coeliac people.
Gluten Friendly and Gut Microbiota
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Results
In vitro experiments
Table 2 reports the fitting parameters for L. acidophilus; the death kinetics generally showed a
downward curve with a shape parameter of the Weibull equation>1. The supplementation of
saline solution with either CB or GFB did not affect the shape of the curve. On the other hand,
the type of bread exerted a significant effect on the death time of the bacterial population; in
fact, the death time was prolonged from 67.46 (CB) to 80.53 (GFB) at 0.4 g L-1 and from 70.28
(CB) to 93.96 (GFB) at 0.8 g L-1.
The effect of GFB on the death time, but not on the shape parameter, was a consequence of
a probable reduction of the death rate in the last part of the death curve, as suggested by the
kinetics reported in Fig 1. The death kinetic of B. animalis subsp. lactis was not affected by the
type of supplementation (S1 Table).
A second assay was run to determine whether the concentration of GFB could cause or
exert a detrimental effect on both L. acidophilus and B. animalis; saline solution was supple-
mented with same the amount used in the first experiment (0.8 g L-1) and with a higher con-
centration (5.0 g L-1). The viable count was not affected by the concentration of bread digesta
(S2 Table).
Finally, saline solution was inoculated with a Gram-positive or a Gram-negative pathogen
(S. aureus and Salmonella Typhimurium); the results for S. aureus are shown in Fig 2. A signifi-
cant difference was found for the sample supplemented with 0.8 g L-1 GFB, which showed a
1-log lower viable count than the sample supplemented with CB. Salmonella sp. experienced a
1.8- and 2.84-log reduction after 6 and 8 days, respectively (Fig 3).
Changes in bacterial populations and the metabolic profile with in vitro
batch culture fermentation: a one-way ANOVA approach
A second step was aimed at assessing the effect of both CB and GFB in batch culture fermenta-
tions. See S1 and S2 Figs for the raw data.
The results of the FISH and SCFA analyses were standardized to the negative control at
time 0 (inoculation time) to exclude the variability due to the type of donor; thus, the results
show the modification of the system compared to the beginning of the experiment and should
be read as increases (positive values) or decreases (negative values). Moreover, each parameter
was analysed through one-way ANOVA to pinpoint significant differences; the homogeneous
group approach was used as an additional tool to uncover a possible trend through time.
Table 3 shows the results for bifidobacteria. The differences amongst the samples were not
significant after 6 h or 24 h, but two statistical groups were recovered after 48 h, i.e., sample E
(coeliac donor with CB) and the other samples. Sample E did not show a significant increase in
the viable count of bifidobacteria (0.27-log increase) probably due to a detrimental effect exerted
Table 2. Fitting parameters of the Weibull equation for the death kinetics of L. acidophilus (mean values ± SE). For each parameter, the letters indi-
cate significant differences (one-way ANOVA and Tukey’s test, P<0.05). CB, control bread; GFB, gluten-friendly bread.
Sample log N0* δ p d.t. R
CB 0.4 g L-1 8.43±0.14A 17.99±0.90A 1.62±0.15A 67.46±2.06A 0.995
GFB 0.4 g L-1 8.38±0.13A 17.43±2.06A 1.40±0.14A 80.53±2.03B 0.994
CB 0.8 g L-1 8.19±0.12A 23.40±2.00B 1.94±0.20A 70.28±2.63A 0.993
GFB 0.8 g L-1 8.56±0.14A 17.57±2.70A 1.27±0.17A 93.96±4.00C 0.990
*log N0, initial cell count (log CFU mL
-1); δ, ﬁrst reduction time (h); p, shape parameter; d.t., death time (h).
doi:10.1371/journal.pone.0162770.t002
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by bread on the microbiota. In the other samples, there was a 0.7–09 log increase, and sample F
(coeliac donor with GFB) experienced a similar trend to that of the samples from healthy donors.
Concerning the outputs for the E. rectale–C. coccoides group (enumerated as Erec482) and
the Bacteroides spp.–Prevotella group (enumerated as Bac303), the statistics highlighted a con-
tinuous rather than discrete distribution of the samples, with 2–4 overlapping homogeneous
groups depending on the time and the type of microorganisms present. The sample distribu-
tion of Bacteroides/Prevotella changed over time; however, the increase/decrease in the absolute
values of the viable count (-0-33-0.26 log CFU mL-1) was slight (S3 Table).
Table 4 shows the effect of bread supplementation on the numbers of the C. hystolyticum
group (Chis150). After 6 h, there was a continuous distribution of samples with 2 well-defined
groups (first group containing samples A and B; second group containing sample E) and an
intermediate class (samples C, D, and F). Thus, sample E (coeliac donor with CB) was not dif-
ferent from samples D and F (negative control and coeliac donor with GFB), although it was
significantly different from the healthy donor samples. Samples F and D experienced a slight
statistical shift towards sample C. This shift was not observed after 24 and 48 h, suggesting that
this result should be confirmed with prolonged experiments and repeated supplementation.
The lactic acid bacteria exhibited a characteristic trend over time, as reported in Table 5.
The 6 h fermentation caused a decrease in the numbers of Lactobacillus/Enterococcus spp. in
Fig 1. Death kinetics of L. acidophilus in a saline solution supplemented with either control (CB) or gluten-friendly bread
(GFB) (0.8 g L-1). The lines represent the best fit through theWeibull equation.
doi:10.1371/journal.pone.0162770.g001
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samples E and F (0.57–0.64 log CFU mL-1). After 24 h, the decrease was again observed in sam-
ple E but not in sample F, which exhibited a trend similar to the samples from healthy donors
(no decrease in the cell count). After 48 h, the samples were distributed in a continuous way,
and sample F was included in the group of healthy donors, as well as in the same group as sam-
ple E, suggesting that the shift observed after 24 h of fermentation was reversible. The statistical
outputs for E. rectale pinpoint a constant distribution, without significant differences amongst
the different samples (S4 Table).
The same approach was used to analyse the SCFA profiles (Tables 6, 7 and 8). The amount
of SCFAs generally had a discrete distribution with well-defined statistical groups and signifi-
cant differences. Acetate increased by 174 mM in sample B after 24 h, whereas the increase was
43–62 mM in the other samples. A similar trend was observed at the end of the assay, although
a further increase was found (Table 6). The increase in propionic acid was slight in the samples
from healthy donors (after 24 and 48 h), whereas the content of this acid increased by 23–37
mM in the samples from coeliac donors (Table 7). After 24 h, butyric acid increased by 17 mM
Fig 2. Viable count of S. aureus in a saline solution supplemented with either control (CB) or gluten-
friendly bread (GFB) (0.2, 0.4 or 0.8 g L-1).Mean values ± standard deviation. The symbols “*” and “**”
denote significant differences (one-way ANOVA and Tukey’s test).
doi:10.1371/journal.pone.0162770.g002
Fig 3. Viable count of Salmonella typhimurium in a saline solution supplemented with either control
(CB) or gluten-friendly bread (GFB) (0.8 g L-1).Mean values ± standard deviation.
doi:10.1371/journal.pone.0162770.g003
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in the negative control D, which experienced the highest increase, followed by the other two
samples from the coeliac donors (E, 7.6 mM; F, 4.1 mM). The results after 48 h revealed an
interesting output; sample E experienced a further increase in butyric acid of 3 mM, and an
increase was found in samples A (2 mM), B (4 mM) and C (6.58 mM); sample F showed a pro-
file similar to the samples from healthy donors, with a net increase in butyric acid of 4.28 mM
(Table 8).
Changes in the bacterial populations and metabolic profile with in vitro
batch culture fermentation: a multivariate approach
The results from the batch cultures were analysed through PCA. SCFA and FISH data were all
used as input, except for the data on the C. hystolyticum and E. rectale–C. coccoides groups due
to the results of one-way ANOVA (no significant differences). Three analyses were run in
order to assess the factorial distribution of the samples as a function of the origin (coeliac or
healthy donors), supplementation (CB or GFB) and time (6, 24, and 48 h), as shown in Figs 4–
6. For each analysis, we reported both the variable (Figs 4A, 5A and 6A) and case distribution
(Figs 4B, 5B and 6B); however, we did not use PCA to discuss why and for which type of vari-
able the samples were different (this topic was addressed in the previous section). We used
PCA to graphically estimate the similarity or dissimilarity amongst the samples. After 6 h, 2
statistical groups could be determined in the multi-factorial space, i.e., the first group including
Table 3. One-way ANOVA (P<0.05) and homogeneous groups based on FISH data for bifidobacteria
(enumerated as Bif164) after 6, 24 and 48 h of fermentation in pH-controlled batch culture systems.
Increases/decreases refer to the inoculum of the negative control. Samples: A, negative control healthy
donors; B, healthy donors + CB; C, healthy donors + GFB; D, negative control coeliac donors; E, coeliac
donors + CB; F, coeliac donors + GFB. CB, control bread; GFB, gluten-friendly bread.
FISH (log cells mL-1) Homogeneous groups
6 h I II III
Sample
E 0.15
F 0.26
D 0.49
B 0.60
A 0.63
C 0.70
24 h
E 0.37
F 0.49
D 0.51
A 0.72
B 0.73
C 0.91
48 h
E 0.27
A 0.65
F 0.68
D 0.70
B 0.72
C 0.93
doi:10.1371/journal.pone.0162770.t003
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the samples from healthy donors (A, B, C) and the second group including the samples from
coeliac donors supplemented with CB or GFB (E and F). The negative control of this latter
group was an outsider and placed in a different region of the factorial space (Fig 4).
After 24 h, the space distribution drastically changed, and many samples experienced a shift
in the plot (Fig 5); the group composed of healthy donors was divided in two sub-groups
because sample B had moved from a different region of the space. A split was also found for
the samples from coeliac donors: both E and F moved away from the negative control, but F
moved in the upper region of the space towards samples A and C. A similar distribution was
found after 48 h, except that samples B and E were in the positive quadrants of factor 2 (upper
region) and the other samples were in the negative region (Fig 6).
Discussion
The role of gut microbiota in health and well-being has been extensively reviewed [30]. Lifestyle,
diet, life stage and some pathologies can strongly affect the qualitative and quantitative composi-
tion of gut microbiota [31,32]. Coeliac people possess altered gut microbiota; in addition, many
researchers pinpointed that dysbiosis dramatically impacts the host physiology [33].
The background of this research was a patent [14,15] focused on the use of microwave for
the detoxification of gluten. The safety of this technology was preliminary assessed on periph-
eral blood mononuclear cells (PBMC) stimulated with phytohaemagglutinin (PHA). The
Table 4. One-way ANOVA (P<0.05) and homogeneous groups based on fluorescence in situ hybrid-
ization (FISH) data for theC. hystolyticum group (enumerated as Chis150) after 6, 24 and 48 h of fer-
mentation in pH-controlled batch culture systems. Increases/decreases refer to the inoculum of the
negative control. Samples: A, negative control healthy donors; B, healthy donors + CB; C, healthy donors
+ GFB; D, negative control coeliac donors; E, coeliac donors + CB; F, coeliac donors + GFB. CB, control
bread; GFB, gluten-friendly bread.
FISH (log cells mL-1) Homogeneous group
6 h I II III
Sample
B -0.27
A -0.18
C -0.10
D 0.15
F 0.17
E 0.32
24 h
C -0.16
F -0.12
A -0.08
B -0.03
E 0.07
D 0.10
48 h
A -0.31
C -0.23
B 0.06
D 0.17
F 0.19
E 0.22
doi:10.1371/journal.pone.0162770.t004
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Table 5. One-way ANOVA (P<0.05) and homogeneous groups based on FISH data for Lactobacillus/
Enterococcus (enumerated with Lab158) after 6, 24 and 48 h of fermentation in pH-controlled batch
culture systems. Increases/decreases refer to the inoculum of the negative control. Samples: A, negative
control healthy donors; B, healthy donors + CB; C, healthy donors + GFB; D, negative control coeliac donors;
E, coeliac donors + CB; F, coeliac donors + GFB. CB, control bread; GFB, gluten-friendly bread.
FISH (log cells mL-1) Homogeneous group
6 h I II III
Sample
F -0.64
E -0.57
D -0.33
C -0.12
A 0.00
B 0.04
24 h
E -0.59
F 0.01
D 0.02
A 0.17
C 0.27
B 0.29
48 h
E -0.53
D -0.29
F -0.02
A 0.14
B 0.19
C 0.30
doi:10.1371/journal.pone.0162770.t005
Table 6. One-way ANOVA (P<0.05) and homogeneous groups based on acetate after 24 and 48 h of
fermentation in pH-controlled batch culture systems. Increases/decreases refer to the inoculum of the
negative control. Samples: A, negative control healthy donors; B, healthy donors + CB; C, healthy donors
+ GFB; D, negative control coeliac donors; E, coeliac donors + CB; F, coeliac donors + GFB. CB, control
bread; GFB, gluten-friendly bread.
Acetate (mM) Homogeneous groups
24 h I II III IV V VI
Sample
C 43.37
A 45.39
D 52.36
F 52.38
E 62.30
B 174.10
48 h
A 43.86
F 52.96
E 57.66
D 61.84
C 62.46
B 258.47
doi:10.1371/journal.pone.0162770.t006
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patent was further improved in terms of combination of microwave power, treatment time and
rest time [18]; however, the effect of this approach on the microbiota of the gut has been never
addressed and this topic has been investigated in the present paper.
Firstly, we aimed to determine whether GFB modifies the qualitative-quantitative composi-
tion of gut microbiota via a two-step plan. The first phase relied on the evaluation of the death
decay of selected strains and focused on the eventual change of shape or kinetics of the
Table 7. One-way ANOVA (P<0.05) and homogeneous groups based on propionate after 24 and 48 h of fermentation in pH-controlled batch culture
systems. Increases/decreases refer to the inoculum of the negative control. Samples: A, negative control healthy donors; B, healthy donors + CB; C, healthy
donors + GFB; D, negative control coeliac donors; E, coeliac donors + CB; F, coeliac donors + GFB. CB, control bread; GFB, gluten-friendly bread.
Propionate (mM) Homogeneous groups
24 h I II III IV V VI
Sample
B -4.31
A -0.76
C 0.97
D 23.16
E 31.19
F 32.71
48 h
A 0.39
B 1.72
C 4.69
D 22.59
F 37.14
E 37.46
doi:10.1371/journal.pone.0162770.t007
Table 8. One-way ANOVA (P<0.05) and homogeneous groups based on butyrate after 24 and 48 h of
fermentation in pH-controlled batch culture systems. Increases/decreases refer to the inoculum of the
negative control. Samples: A, negative control healthy donors; B, healthy donors + CB; C, healthy donors
+ GFB; D, negative control coeliac donors; E, coeliac donors + CB; F, coeliac donors + GFB. CB, control
bread; GFB, gluten-friendly bread.
Butyrate (mM) Homogeneous group
24 h I II III IV V VI
Sample
C -3.63
B -0.39
A 2.43
F 4.07
E 7.59
D 17.42
48 h
A 2.25
B 4.02
F 4.28
C 6.59
E 10.67
D 15.04
doi:10.1371/journal.pone.0162770.t008
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Fig 4. PCA based on the SCFA and FISH data after 6 h of fermentation. A) Variable projection; B) Case
projection. Samples: A, negative control healthy donors; B, healthy donors + CB; C, healthy donors + GFB; D,
negative control coeliac donors; E, coeliac donors + CB; F, coeliac donors + GFB. CB, control bread; GFB,
gluten-friendly bread. Variables: 1, bifidobacteria; 2, E. rectale-C. coccoides; 3, Bacteroides/Prevotella; 5,
Lactobacillus/Enterococcus; AC, acetate; BUT, butyrate; PROP, propionate.
doi:10.1371/journal.pone.0162770.g004
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Fig 5. PCA based on the SCFA and FISH data after 24 h of fermentation in pH-controlled batch cultures. A)
Variable projection; B) Case projection.
doi:10.1371/journal.pone.0162770.g005
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Fig 6. PCA based on the SCFA and FISH data after 48 h of fermentation in pH-controlled batch cultures. A)
Variable projection; B) Case projection.
doi:10.1371/journal.pone.0162770.g006
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characteristic curve of each microorganism. For this step, theWeibull function pinpointed some
interesting results. Namely, the Weibull equation possesses two fitting parameters (δ and p for
the first reduction time and the shape parameter, respectively), which take into account two dif-
ferent phenomena of death kinetics, i.e., the prolongation of the shoulder phase (a benefit in the
first step of the kinetics) and tailing (i.e., prolonged survival). As an additional tool, we used a
slightly modified Weibull equation to evaluate death (or survival time). This last parameter is
generally affected by the shoulder and tail, as well as the death rate. Supplementation with GFB
affected neither the first reduction time nor the shape parameter of L. acidophilus but exerted a
significant effect on the death time. GFB probably did not induce resistance in cells but lowered
the death rate by exerting a protective effect. However, this effect was quite different from the
protection exerted by some prebiotics. For example, fructooligosaccharides and inulin induced a
prolonged tail as a result of a general stress response mechanism due to starvation [34,35],
whereas GFB resulted in a reduction of the death kinetics but not a tail effect.
The lowering of death rate in the bacterial curve, as well as growth enhancement, is gener-
ally the result of a protective compound and has observed previously in some cell-free filtrates
or bifidogenic factors. The effects of these factors were variable and described as growth
enhancement due to membrane permeability, combating cell aging, etc. [36,37].
The high temperature generated by the microwave treatment and applied to the hydrated
wheat caryopses for a short period of time to detoxify gluten may break the hydrogen bonds
between the glutamine residues in proteins when in their native form in protein bodies, induc-
ing a rearrangement of the secondary and tertiary structure of the gluten protein, with a differ-
ent spatial conformation of the toxic sequences [16]. We also postulated that the
rearrangement of some of the gluten protein structure involves the exposure of positive charges
[18]. Positive molecules, namely cationic peptides, can exert a strong antibacterial effect
because they supposedly act at the cytoplasmic membrane, leading to permeabilisation and
eventually membrane disruption. Arginine and lysine residues play a major role in this process
[38]. Moreover, the interaction of antimicrobial peptides with anionic membrane phospholip-
ids is a key factor in killing bacteria [38]. To date, it is not clear whether the outer membrane of
Gram-negative bacteria can exert a positive or negative effect. Our results suggest that the
outer membrane did not play a role due to the significant antibacterial effect on both Salmo-
nella Typhimurium and S. aureus.
Teichoic acid can act negatively on cationic peptides because they have a negative charge,
catch positive molecules and decrease their potential towards cells [38]. This idea could par-
tially explain how GFB did not exert a negative effect on lactobacilli and bifidobacteria but did
for S. aureus, and this difference might be the result of the unique structure of the cell wall and
teichoic acids in lactobacilli, as described by Chapot-Chartier and Kulakauskas [39].
After this preliminary evaluation in strictly controlled conditions, we moved to a complex
ecosystem to assess whether GFB can affect the evolution of heterogeneous microbiota. Two
variables were assessed: the type of bread (CB and GFB) and the subject (coeliac or healthy peo-
ple). The experiments were performed using 6 different subjects, and a negative control (batch
culture inoculated with faecal microbiota but not supplemented with any type of bread) was
also added for each subject. In addition, we also assumed that the faecal microbiota could expe-
rience a qualitative-quantitative change per se (decrease or increase without supplementation
due to a “donor effect”) or after bread supplementation (change due a “bread effect”). Thus, we
used a static approach to standardize the data to the negative control at each sampling time.
For each group (healthy subjects, A-C; coeliac subjects, D-F), the standardized values of the
negative controls (A and D) showed the donor effect not related to bread supplementation.
Therefore, a negative value pinpointed that bread supplementation caused a decrease in the
viable count, whereas a positive value highlighted an increase.
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Some groups were chosen as tests to assess the effect of CB and GFB, such as lactobacilli,
bifidobacteria, Bacteroidetes, eubacteria and clostridia. Bifidobacteria can produce vitamins
(e.g., K, B12, biotin, folate, thiamine) [31]. The synthesis of secondary bile acids is mediated via
Lactobacillus spp. and Bifidobacterium spp. [31]. Moreover, Bifidobacterium spp. can also help
prevent pathogenic infection through the production of acetate [40]. To date, the role of Bac-
teroides is controversial: some authors have postulated a positive impact, whereas other
researchers have found a strong correlation of these microorganisms with CD [41,42] and a
possible role in the pro-inflammatory response [42], mucin degradation and increased perme-
ability of the small intestine [43,44]. E. rectale (now reclassified as Agathobacter rectalis) [45] is
generally related to bifidobacteria, as it produces butyrate from acetate [46], with a beneficial
effect on the host.
The most valuable results were found for lactobacilli and bifidobacteria. In fact, the stan-
dardised values of lactobacilli from coeliac donors after 6 h were negative, suggesting that the
lactobacilli population suffered a type of stress that was enhanced by bread supplementation.
The shift from negative to positive values in coeliac subjects in the presence of GFB (sample F)
suggests that the supplementation suddenly interrupted this stress and beneficially modulated
the microbiota composition. However, this effect was reversible because the samples experi-
enced a partial shift after 48 h, suggesting that a prolonged and a beneficial effect could also be
the result of prolonged supplementation. The experimental data from the batch cultures also
confirmed the ability of GFB to promote the growth of Lactobacillus spp. The shift was much
stronger in coeliac donors probably due the unbalanced microbiota composition compared to
healthy subjects.
Differently from the screening, GFB exerted a positive effect on the bifidobacteria numbers
of coeliac donors, although the effect was found after only 48 h. This result, along with the
death kinetics data in saline solution, suggests that bifidobacteria probably require prolonged
supplementation.
The same approach was used to model and analyse SCFA profiles. There is growing recogni-
tion of the role of SCFAs in immune function and inflammation in tissues [47]. Moreover,
SCFAs can act as key sources of energy for colorectal tissues and bacteria and promote cellular
mechanisms that maintain tissue integrity [48–50]. The data were quite variable, and bread
supplementation did not exert a clear effect. To better understand this scenario, we decided to
combine the SCFA data with the viable counts and pinpoint the changes at a global level.
Thus, the last statistical analysis (PCA) pinpointed a change in the ecosystem, and this effect
was clearly distinguishable after 24 hours for sample F (coeliac donor+GFB), which moved
from the region of coeliac people to healthy subjects. Thus suggests that GFB can cause a
change in the whole ecosystem and exert a key role in the fight against the dysbiosis in coeliac
people.
This study provides new insights into the role of GFB on the qualitative-quantitative modu-
lation of microbiota in simple or complex systems. The first step pinpointed that GFB has an
important role in the prolongation of the survival of L. acidophilus and the antibacterial effect
towards S. aureus and Salmonella Typhimurium. In a complex ecosystem, such as gut micro-
biota, GFB induced a beneficial modulation in terms of bifidogenic effects and on the growth
of lactobacilli. Moreover, a final multivariate approach combining both the viable count and
SCFA profile suggested that GFB causes a shift in the whole ecosystem. Therefore, this paper
provides findings supporting the utilization of GFB to modulate the composition and meta-
bolic profile of the intestinal microbiota in coeliac individuals. The applicability of such
changes remains to be shown in a 3-stage continuous in vitro colonic model and an in vivo
trial.
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